Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%. Scope of the Report: This report focuses on the Irritable Bowel Syndrome (IBS) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Allergan Valeant Pharmaceuticals Takeda Sucampo Pharmaceuticals McNeil Consumer Healthcare Sebela Pharmaceuticals Astellas Pharmaceuticals IM HealthScience Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers IBS-D Drug IBS-C Drug Other Market Segment by Applications, can be divided into Women Men There are 15 Chapters to deeply display the global Irritable Bowel Syndrome (IBS) market. Chapter 1, to describe Irritable Bowel Syndrome (IBS) Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Irritable Bowel Syndrome (IBS), with sales, revenue, and price of Irritable Bowel Syndrome (IBS), in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Irritable Bowel Syndrome (IBS), for each region, from 2012 to 2017; Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017; Chapter 12, Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Irritable Bowel Syndrome (IBS) Introduction 1.2 Market Analysis by Type 1.2.1 IBS-D Drug 1.2.2 IBS-C Drug 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Women 1.3.2 Men 1.4 Market Analysis by Regions 1.4.1 North America (USA, Canada and Mexico) 1.4.1.1 USA Market
